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Abstract
Background: Apolipoprotein E (ApoE) gene has been reported to be associated with migraine and tension-type
headache (TTH), but the results are conflicting. This study aimed to evaluate the association of ApoE with migraine
by a meta-analysis.
Methods: MEDLINE, ISI Web of Knowledge, The Cochrane Central Register of Controlled Trials, and EMBASE
databases were searched to identify eligible studies published in English from 2000 to 2014. Data were extracted
using standardized forms. The association was assessed by relative risk (RR) with 95 % confidence intervals (CIs)
using a fixed or random effects model.
Results: Four studies, comprising 649 migraineurs, 229 TTH subjects and 975 controls, met all the criteria and were
included in the meta-analysis. No significant difference was found comparing genotypic and allelic frequencies in
the case of migraineurs versus controls and TTH subjects versus controls. Only when migraineurs and TTH subjects
were considered as a whole group, ApoE4 was found to increase the relative risk of headache by 1.48 (95 % CI 1.16,
1.90; P = 0.002), compared to controls.
Conclusions: ApoE ε4 allele is not associated with migraine susceptibility, but is positively related to headache
(including migraine and TTH).
Background
Migraine is a common neurovascular disorder, charac-
terized by recurrent episodes of headache and the
dysfunction of the autonomic nervous system, affecting
10–20 % of the population [1, 2]. Although the patho-
physiology of migraine is largely unknown, a neurogenic
hypothesis of migraine has been proposed [3]. In par-
ticular, the genes involved in regulation of the endothelin
system are proved to be promising candidates in mi-
graine susceptibility [4, 5].
Apolipoprotein E (ApoE) is a 299 amino acid protein,
encoded by a gene located on chromosome 19cen-q13.2
[6, 7]. ApoE gene has three common alleles (ɛ2, ɛ3, ɛ4)
that encode three isoforms (APOE2, APOE3, APOE4).
Several studies have shown a relationship between
APOE polymorphism and the expression of the cyto-
kines involved in migraine and TTH [8, 9]. Moreover,
several studies investigated the association between
APOE single nucleotide polymorphism (SNP) and mi-
graine, but the results are conflicting [10–13].
Therefore, to define further the disease risk associ-
ated with APOE polymorphism, in this study we per-
formed a meta-analysis of all related studies that




Eligible studies were identified by searching on web-
based databases (MEDLINE 2000 to 2014, ISI Web of
Knowledge 2000 to 2014, The Cochrane Central Regis-
ter of Controlled Trials 2000 to 2014, and EMBASE)
with no language restrictions. Search terms were “apoli-
poprotein E”, “APOE”, “ɛ2”, “ɛ3”, “ɛ4”, “APOE2”,
“APOE3”, “APOE4”, “migraine”, “headache” and “Poly-
morphism”. Potentially relevant studies were retrieved
and reviewed by 2 reviewers. All case–control studies
with extractable data were included. Included studies
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were published as full-length articles in peer-reviewed
journals.
Data extraction and quality assessment
Studies were included for meta-analysis if they met the
following criteria: (1) the association between APOE and
migraine was examined by using a population-based,
case–control design; (2) migraine was diagnosed using
an international standard; (3) genotype or allele frequen-
cies were reported in both cases and controls; (4) the
genotype frequencies in control groups were consistent
with Hardy-Weinberg equilibrium.
Statistical analysis
Heterogeneity across the eligible studies was tested using
Q-test, and it was considered statistically significant
when P < 0.1. Heterogeneity was also quantified with I2
test (I2 = (Q− df) / Q × 100 %. I2 values of above 25 %,
50 %, and 75 % were taken as indicators of mild, modest,
and high heterogeneities, respectively. When the effects
were assumed to be homogeneous (P >0.1, I2 < 50 %),
the fixed-effects model was used; otherwise, the
random-effects model was more appropriate. The meta-
analyses were performed using Stata Version 12.0 soft-
ware (Stata Corp., College Station, TX, USA).
Results
Study inclusion and characteristics
As a result of our literature search, a total of four pub-
lished articles reported on the relationship between
APOE SNP and migraine and met the inclusion criteria.
Rainero et al. divided the subjects into three subgroups:
migraine with aura; migraine without aura; and mixed
headaches (migraine associated with tension-type head-
ache) [10]. Stuart et al. separated migraineurs into MA
and MO groups. The other two reports investigated a
possible association of APOE polymorphism with mi-
graine and TTH [11, 12].
Results of meta-analyses
Total 649 migraineurs, 229 TTH subjects and 975 con-
trols were genotyped for APOE polymorphism. In the
four studies, the distribution of the genotypes in control
groups was in Hardy–Weinberg equilibrium (P < 0.05).
No significant difference was found between genotypic
and allelic frequencies in the case of migraineurs versus
controls and TTH subjects versus controls. Exclusively
in the comparison between subjects with the allele E2
vs. E3 + E4, pooled RR with fixed effect was 1.49 (95 %
CI 1.11, 2.01; P = 0.009, I2 = 74.1 %). This significance
disappeared with random effect (RR1.82; 95 %CI 0.92,
3.61). While E4 gene increased the relative risk of head-
ache by1.48 (95 % CI 1.16, 1.90; P = 0.002), they did not
show any effect when migraineurs and TTH subjects
were taken as a reference category (Figs. 1 and 2).
Meta-analysis of subgroups
To determine genetic heterogeneity of E2, MO and MA
subgroups were also compared vs. controls. No signifi-
cant difference between cases and controls was observed
(Figs. 3 and 4).
Discussion
The results of this meta-analysis suggest that there is no
association between migraine and APOE polymorphism,
even in subgroups analyses. However, when migraineurs
and TTH subjects as a whole headache group were ex-
amined, a significant association was found between
headache and E4 gene polymorphism. Migraineurs and
TTH subjects carrying the allele E4, using fixed effects,
showed a modest heterogeneity but significantly in-
creased disease risk. The modest heterogeneity is the
most likely explanation for the differences in ethnicity or
in sample characteristics. Our data therefore partially
confirm previous studies suggesting that this poly-
morphism represents a genetic risk factor for patients
with migraine or TTH.
Nitric oxide (NO) plays an essential role in the patho-
genesis of both migraine and TTH [14, 15]. Moreover,
the production of NO is dependent on APOE HhaI poly-
morphism [16]. NO production is greater in APOE4 car-
riers with characteristically high levels of oxidative stress
than in APOE3 carriers after closed head injury and
stroke [17]. In addition, higher inflammation activity was
associated with APOE ɛ4 gene compared to APOE ɛ3
gene [18]. Furthermore, APOE polymorphism influences
the expression of the cytokines involved in migraine and
TTH [8, 9, 19]. These results suggest that APOE4 may
be associated with more serious tissue damage and
higher disease susceptibility. Similarly, we found that
APOE4 increased the relatively higher risk of headache
compared to APOE3.
There are some limitations in our study. First, since
migraine is a complex and heterogeneous disorder with
a wide clinical spectrum, patients with different clinical
phenotypes may not sufficiently capture this variability
and may result in misclassification. Second, we only
chose three genotypes in our study, despite various ge-
notypes of APOE. Third, the lack of individual data has
restricted further adjustments for the subgroup analysis
for TTH. Fourth, the analysis was performed on a rela-
tively small number of retrospective case–control stud-
ies, and the subjects included in these studies are also
limited. Further population-based studies with larger
sample size are necessary to confirm our conclusions.
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Fig. 1 Forest plot of comparison: SNP APOE E3 of migraineurs and TTHs versus control. SNP APOE E3 was shown to have no significant
association with migraineurs and TTH
Fig. 2 Forest plot of comparison: SNP APOE E4 of migraineurs and TTHs versus control. SNP APOE E4 was shown to have significant association
with migraineurs and TTH
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Fig. 3 Forest plot of comparison: SNP APOE E2 of migraineurs of MO versus control. SNP APOE E2 was shown to have no significant association
with migraineurs and TTH
Fig. 4 Forest plot of comparison: SNP APOE E2 of migraineurs of MA versus control. SNP APOE E2 was shown to have no significant association
with migraineurs and TTH
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Conclusions
In summary, the evidence from the present meta-analysis
showed that APOE4 is not associated with migraine or
TTH, but is related to headache (including migraine
and TTH), suggesting a nonspecific role for the risk of
headache.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JM: participated in the design of the study, acquisition of data, analysis and
interpretation of data, and drafted the manuscript. FW: participated in the
design of the study, acquisition of data, analysis and interpretation of data.
WZ: participated in acquisition of funding, design of the study and general
supervision of the research group. XZ: participated in acquisition of funding,
design of the study and general supervision of the research group. All
authors read and approved the final manuscript.
Acknowledgements
We thank Dr. Yingqun Wang from Biomedsci (Biomedsci.net) who kindly
proofread the manuscript.
Author details
1Department of Neurology, Affiliated Zhongshan Hospital of Xiamen
University, 201 Hubinnan Road, Xiamen 361004, China. 2Department of
Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic
Resonance, Xiamen University, Xiamen 361005, China. 3College of Computer
Engineering, Jimei University, Xiamen 361021, China.
Received: 14 October 2014 Accepted: 17 July 2015
References
1. Silberstein SD. Migraine. Lancet. 2004;363(9406):381–91.
2. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic
manifestations: focus on epilepsy and migraine. Lancet Neurol.
2006;5(2):148–57.
3. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci.
2003;4(5):386–98.
4. Moskowitz MA. Pathophysiology of headache–past and present. Headache.
2007;47 Suppl 1:S58–63.
5. Lemos C, Neto JL, Pereira-Monteiro J, Mendonca D, Barros J, Sequeiros J, et al.
A role for endothelin receptor type A in migraine without aura susceptibility?
A study in Portuguese patients. Eur J Neurol. 2011;18(4):649–55.
6. Lynch JR, Morgan D, Mance J, Matthew WD, Laskowitz DT. Apolipoprotein E
modulates glial activation and the endogenous central nervous system
inflammatory response. J Neuroimmunol. 2001;114(1-2):107–13.
7. Kaur M, Balgir PP. APOE2 and consanguinity: a risky combination for
Alzheimer's disease. J Alzheimers Dis. 2005;8(3):293–7.
8. Perini F, D'Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, et al. Plasma
cytokine levels in migraineurs and controls. Headache. 2005;45(7):926–31.
9. Tsoi LM, Wong KY, Liu YM, Ho YY. Apoprotein E isoform-dependent
expression and secretion of pro-inflammatory cytokines TNF-alpha and IL-6
in macrophages. Arch Biochem Biophys. 2007;460(1):33–40.
10. Rainero I, Grimaldi LM, Salani G, Valfre W, Savi L, Rivoiro C, et al.
Apolipoprotein E gene polymorphisms in patients with migraine. Neurosci
Lett. 2002;317(2):111–3.
11. Joshi G, Pradhan S, Mittal B. Vascular gene polymorphisms (EDNRA -231 G >
A and APOE HhaI) and risk for migraine. DNA Cell Biol. 2011;30(8):577–84.
12. Gupta R, Kumar V, Luthra K, Banerjee B, Bhatia MS. Polymorphism in
apolipoprotein E among migraineurs and tension-type headache subjects. J
Headache Pain. 2009;10(2):115–20.
13. Stuart S, Donges B, Murrell M, Haupt LM, Lea RA, Griffiths LR. Investigation
of APOE isoforms and the association between APOE E3 and E4 with
migraine in the Australian Caucasian population. Neuroreport.
2013;24(10):499–503.
14. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of
migraine and other vascular headaches. Cephalalgia. 1995;15(2):94–100.
15. Ashina M. Neurobiology of chronic tension-type headache. Cephalalgia.
2004;24(3):161–72.
16. Czapiga M, Colton CA. Microglial function in human APOE3 and APOE4
transgenic mice: altered arginine transport. J Neuroimmunol. 2003;134(1-2):44–51.
17. Colton CA, Brown CM, Cook D, Needham LK, Xu Q, Czapiga M, et al. APOE
and the regulation of microglial nitric oxide production: a link between
genetic risk and oxidative stress. Neurobiol Aging. 2002;23(5):777–85.
18. Guo L, LaDu MJ, Van Eldik LJ. A dual role for apolipoprotein e in
neuroinflammation: anti- and pro-inflammatory activity. J Mol Neurosci.
2004;23(3):205–12.
19. Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX,
et al. Apolipoprotein E genotype and circulating interleukin-10 levels in
patients with stable and unstable coronary artery disease. J Am Coll Cardiol.
2006;48(12):2471–81.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Miao et al. BMC Neurology  (2015) 15:138 Page 5 of 5
